Showing results (191-200 of 329) with videos related to
Sort By:
Pageof 33
European Heart Journal|August 2, 2011
Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomesRobert F Storey, Richard C Becker, Robert A Harrington, et al.American Heart Journal|June 2, 2015
Biomarkers for risk stratification of patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention: Insights from the Platelet Inhibition and Patient Outcomes trialMatthijs A Velders, Lars Wallentin, Richard C Becker, et al.American Heart Journal|August 2, 2017
Brain-derived neurotrophic factor rs6265 (Val66Met) polymorphism is associated with disease severity and incidence of cardiovascular events in a patient cohortRong Jiang, Michael A Babyak, Beverly H Brummett, et al.Clinical Chemistry|December 1, 2011
Cystatin C and estimated glomerular filtration rate as predictors for adverse outcome in patients with ST-elevation and non-ST-elevation acute coronary syndromes: results from the Platelet Inhibition and Patient Outcomes studyÅxel Akerblom, Lars Wallentin, Agneta Siegbahn, et al.American Heart Journal|September 18, 2012
Prior smoking status, clinical outcomes, and the comparison of ticagrelor with clopidogrel in acute coronary syndromes-insights from the PLATelet inhibition and patient Outcomes (PLATO) trialJan H Cornel, Richard C Becker, Shaun G Goodman, et al.Circulation|November 15, 2006
First-in-human experience of an antidote-controlled anticoagulant using RNA aptamer technology: a phase 1a pharmacodynamic evaluation of a drug-antidote pair for the controlled regulation of factor IXa activityChristopher K Dyke, Steven R Steinhubl, Neal S Kleiman, et al.American Heart Journal|December 9, 2008
Clopidogrel use and bleeding after coronary artery bypass graft surgeryJohn Hyung-Jun Kim, L Kristin Newby, Robert M Clare, et al.American Heart Journal|March 1, 2006
Initial experience with an intravenous P2Y12 platelet receptor antagonist in patients undergoing percutaneous coronary intervention: results from a 2-part, phase II, multicenter, randomized, placebo- and active-controlled trialAdam B Greenbaum, Cindy L Grines, John A Bittl, et al.Journal of Psychosomatic Research|January 22, 2017
Associations between positive emotional well-being and stress-induced myocardial ischemia: Well-being scores predict exercise-induced ischemiaJacob P Feigal, Stephen H Boyle, Zainab Samad, et al.Circulation|June 29, 2011
Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trialKenneth W Mahaffey, Daniel M Wojdyla, Kevin Carroll, et al.Pageof 33